Cannabidiol is the major nonpsychoactive component of Cannabis sativa. Over the centuries, a number of medicinal preparations derived from Cannabis sativa have been employed for a variety of disorders, including gout, rheumatism, malaria, pain, and fever. These preparations were widely employed as analgesics by Western medical practitioners in the 19th century. More recently, there is clinical evidence suggesting efficacy in HIV-associated neuropathic pain, as well as spasms associated with multiple sclerosis.
CBD oil is extracted from industrial hemp. Unlike medical marijuana the hemp used for producing CBD oil contains very low concentrations of THC, which provides the euphoric effect of marijuana. It is believed that the cannabidiol, cannabinol, cannabichromene may be responsible for some of the plant?s many putative medicinal properties. In animal studies, cannabidiol (CBD) has been receiving growing attention for its antiemetic, anticonvulsant, antinflammatory, and antipsychotic properties. This broad range of therapeutic effects may be a result of CBD?s complex pharmacological mechanisms.
In searching PubMed 34 studies can be found when searching for the topic CBD or cannabidiol. In early studies researchers did not find any subjective or physiological effects with oral or intravenous CBD (100 mg PO and 30 mg IV) among healthy volunteers. Experimental studies suggest that high-dose CBD may decrease anxiety and increase mental sedation in healthy individuals. Clinical trials suggest the high-dose CBD may be useful for the treatment of social anxiety disorder, and possibly, insomnia and epilepsy.
Unlike medical marijuana products that are produced using CBD oil are legal in all states. These products are classified as dietary supplements. Life Science Products is one company who has produced products based on CBD. LSP is committed to providing consumers access to plant based products that contribute to a healthy life.
